Characterisation of immune responses in type I interferon associated diseases

Gül, Ersin
Type-I interferonopathies are a heterogeneous group of diseases arising from deregulation in nucleic acid sensing pathways, leading to constitutive type-I interferon release and pathology. DNA damage, if not repaired can also potentially activate such pathways. To test the hypothesis that 2 different DNA damage repair and immune deficiencies, Ataxia telangiectasia (AT) and Artemis deficiency could suffer from clinical manifestations associated with elevated type I IFN response, we compared the immune status of AT and Artemis deficient patients to healthy controls and to two patients with confirmed type I interferonopathies (one SAVI (STING-associated vasculopathy with onset in infancy) and one TREX-1 deficient patient diagnosed with Aicardi-Goutières Syndrome (AGS)). Our results demonstrated that type-I and III interferon signatures were elevated in plasma and peripheral blood cells of AT and Artemis deficient patients. Specifically, compared to healthy controls, circulating IP-10 (9- and 14-fold), IFN (5- and 7-fold) and IFN1 (4- and 5-fold) concentrations were significantly higher in AT and Artemis deficient patients, respectively. Moreover, AT and Artemis deficient peripheral blood mononuclear cells (PBMC) secreted ~4- and ~5 fold more IFN-α than healthy controls in the absence of any stimulation. This exaggerated response was still maintained when cells were stimulated with the STING ligand 2’3’-cGAMP (6- and 31-fold more IFN secretion from AT and Artemis deficient cells). Measurement of phosphorylated STAT1 concentrations within PBMCs revealed elevated levels in AT and Artemis deficient patients with respect to healthy controls. These results suggest that AT and Artemis deficient patients have immune features consistent with elevated type I IFN signature. Next, we hypothesized that aberrant IFN production could activate neutrophils and contribute to tissue damage. Herein, we show for the first time that neutrophils of AT, Artemis deficient and SAVI patients spontaneously produced neutrophil extracellular traps (NETs). Consistent with neutrophil activation, plasma elastase was significantly higher in all tested patient groups suggesting that neutrophils might be contributing to tissue damage in classical and proposed type-I interferonopathies.


Differential activation of immune cells by commensal versus pathogen-derived bacterial DNA
Günalp, Sinem; Gürsel, Mayda; Department of Biology (2015)
Immunological mechanisms making contribution to discriminating signals obtained from commensal versus pathogenic bacteria is an active area of research and recent evidence proposes that commensals and pathogens might express discrete variants of pathogen associated molecular patterns (PAMP). We hypothesized that as a major member of PAMP, bacterial DNA (bacDNA) originating from commensals versus pathogens might possess distinct immunostimulatory activities, enabling their dis- crimination by the immune syst...
Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes.
Erikçi, E; Gürsel, Mayda; Gürsel, I (2011-02-01)
The immunogenicity of a vaccine formulation is closely related to the effective internalization by the innate immune cells that provide prolonged and simultaneous delivery of antigen and adjuvant to relevant antigen presenting cells. Endosome associated TLR9 recognizes microbial unmethylated CpG DNA. Clinical applications of TLR9 ligands are significantly hampered due to their pre-mature in vivo digestion and rapid clearance. Liposome encapsulation is a powerful tool to increase in vivo stability as well as...
Building Dicer1 regulation network of mouse liver hepatocytes
Ünsal, Şeyma; Beyge, Mahmut; Aydın Son, Yeşim (2012-06-29)
RNA induced gene silencing complex (RISC) has a role in many cellular processes which includes regulation of gene expression, immune response, cell differentiation and embryonic development. Dicer protein is a key regulator of these processes. Dicer1 specifically has central role in maturation of RISC substrate RNA and RISC assembly in mouse. Here the results of a microarray study that investigates the molecular level changes in dicer1 knockout mouse liver hepatocytes is re-analysed and the differentially r...
Selective High Binding Affinity of Azacyanines to polyd(A) center dot polyd(T) center dot polyd(T) Triplex: The Effect of Chain Length and Branching on Stabilization, Selectivity and Affinity
Tutuncu, Serra; Guloglu, Sercan; Kucukakdag, Ayca; Persil Çetinkol, Özgül (2018-12-06)
Triplex nucleic acid structures receive considerable attention due to their possible role in anti-gene therapy, several diseases as Friedreich's ataxia and Deoxyribonucleic acid (DNA) based nano-structures. The modulation of triplex formation and its stabilization using small molecules is one way to enhance their utility in such applications. Here, we synthesized five new Azacyanines (Azaethyl (2 b), Azapropyl (2 c), Azaisopropyl (2 d), Azabutyl (2 e), Azaisobutyl (2 f)) and assessed their affinity and sele...
Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
Kayaoğlu, Başak; Yilmaz, Naz Surucu; Charbonnier, Louis Marie; Geckin, Busranur; Akcay, Arzu; Eltan, Sevgi Bilgic; Ozturk, Gulyuz; ÖZEN, AHMET OĞUZHAN; Karakoc-Aydiner, Elif; Chatila, Talal A.; Gürsel, Mayda (2021-01-01)
Purpose Patients with heterozygous gain-of-function (GOF) mutations in STAT1 frequently exhibit chronic mucocutaneous candidiasis (CMC), immunodeficiency and autoimmune manifestations. Several treatment options including targeted therapies and hematopoietic stem cell transplantation (HSCT) are available for STAT1 GOF patients but modalities and outcomes are not well established. Herein, we aimed to unravel the effect of ruxolitinib as a bridge therapy in a patient with sporadic STAT1 T385M mutation to manag...
Citation Formats
E. Gül, “Characterisation of immune responses in type I interferon associated diseases,” M.S. - Master of Science, Middle East Technical University, 2016.